Q2 26 EPS
$0.44
BEAT +10.66%
Est. $0.40
Q2 26 Revenue
$18.92B
BEAT +0.13%
Est. $18.89B
vs S&P Since Q2 26
-35.2%
TRAILING MARKET
ACI -24.4% vs S&P +10.7%
Market Reaction
Did ACI Beat Earnings? Q2 2026 Results
Albertsons delivered a stronger-than-expected second quarter for fiscal 2025, posting adjusted EPS of $0.44 against a consensus estimate of $0.40, a beat of 10.66%, as pharmacy strength and surging digital engagement drove the headline numbers. Net s… Read more Albertsons delivered a stronger-than-expected second quarter for fiscal 2025, posting adjusted EPS of $0.44 against a consensus estimate of $0.40, a beat of 10.66%, as pharmacy strength and surging digital engagement drove the headline numbers. Net sales reached $18.92 billion, up 2.0% year-over-year and just ahead of the $18.89 billion analysts had expected, with identical sales rising 2.2% after adjusting for a Colorado labor strike and digital sales climbing 23% while loyalty membership grew 13% to 48.7 million members. The primary headwind was margin compression, as gross margin narrowed to 27.0% from 27.6% a year earlier, reflecting the lower-margin profile of pharmacy and higher delivery costs tied to digital expansion, pulling adjusted EBITDA down to $848.40 million from $900.60 million. On the capital front, the company unveiled a $750 million accelerated share repurchase agreement with JPMorgan Chase, signaling confidence in its trajectory. Management responded to the top-line momentum by nudging full-year identical sales guidance to 2.2% to 2.75% and raising adjusted EPS guidance to $2.06 to $2.19 per share.
Key Takeaways
- • Identical sales increased 2.2% (adjusted), with strong pharmacy sales as the primary driver
- • Digital sales increased 23%
- • Loyalty members grew 13% to 48.7 million
- • Productivity initiatives offset inflationary pressures and funded customer value proposition investments
- • Selling and administrative expenses leveraged down 40 basis points as a percentage of revenue due to employee cost leverage and lower merger-related costs
ACI YoY Financials
Q2 2026 vs Q2 2025, source: SEC Filings
“In the second quarter, we delivered solid operating and financial results while continuing to invest in our core business and elevate the customer experience. Strong performance against our strategic priorities fueled deeper engagement across our digital platforms, resulting in outsized growth in digital sales, pharmacy, and loyalty membership. Our productivity engine continued to offset inflationary pressures and fund investments in areas that matter most to our customers, including fresh categories and omnichannel convenience.”
— Susan Morris, Q2 2026 Earnings Press Release
ACI Earnings Trends
ACI vs Market 30 Day Price Reactions
30-day stock return vs benchmark after each earnings
ACI EPS Trend
Earnings per share: estimate vs actual
ACI Revenue Trend
Quarterly revenue: estimate vs actual
ACI Quarterly Results
5 quarters of earnings data
| Quarter | EPS Est. | EPS Act. | Surprise | Revenue | Rev. Surprise |
|---|---|---|---|---|---|
| Q4 26 BEAT FY | $0.44 | $0.48 | +9.26% | $20.25B | -0.99% |
| FY Full Year | $2.15 | $2.18 | +1.61% | $83.17B | -0.16% |
| Q3 26 BEAT | $0.68 | $0.72 | +5.60% | $19.12B | -0.23% |
| Q2 26 BEAT | $0.40 | $0.44 | +10.66% | $18.92B | +0.13% |
| Q1 26 BEAT | $0.54 | $0.55 | +2.17% | $24.88B | +0.76% |
| Q4 25 BEAT FY | $0.41 | $0.46 | +11.06% | $18.80B | +0.05% |
| FY Full Year | $2.30 | $2.34 | +1.85% | $80.39B | -0.29% |